Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Dec;72(6):2137–2143. doi: 10.1172/JCI111178

A high molecular weight form of somatostatin-28 (1-12)-like immunoreactive substance without somatostatin-14 immunoreactivity in the rat pancreas. Evidence that somatostatin-14 synthesis can occur independently of somatostatin-28.

Y C Patel
PMCID: PMC437054  PMID: 6139388

Abstract

Synthesis of somatostatin-14 (S-14) could occur through direct enzymatic processing of precursor somatostatin (prosomatostatin) or via sequential breakdown of prosomatostatin leads to somatostatin-28 (S-28) leads to S-14. If direct processing is important, it should theoretically generate S-14 and a molecule equivalent to prosomatostatin without the S-14 sequence. In an attempt to identify such a molecule, I characterized the molecular forms of S-28(1-12)-like immunoreactivity (S-28(1-12) LI) in the rat pancreas and compared the relative amounts of these forms with those of S-14-like immunoreactivity (S-14 LI). Pancreatic extracts were chromatographed on Sephadex G-50 and Sephadex G-75 columns (Pharmacia Fine Chemicals Inc., Piscataway, NJ) under denaturing conditions and immunoreactivity in the eluting fractions was analyzed by region-specific radioimmunoassays (RIAs). For RIA of S-28(1-12) LI we used a newly developed rabbit antibody R 21 B, 125I-Tyr12 S-28(1-14), and S-28(1-12) standards. This system detects S-28, S-28(1-12), high molecular weight forms of S-28(1-12), but not S-14. S-14 LI was measured using antibody R149, which detects S-14, S-28, and higher molecular weight S-14-like substances, but not S-28(1-12). Three forms of S-28(1-12) LI were identified: Mr 9,000-11,000, Mr 1,200 (corresponding to S-28(1-12), and Mr less than 1,000, comprising, respectively, 35, 53, and 12% of total immunoreactivity. The relative abundance of the 9,000-11,000 mol wt S-28(1-12) LI material was unchanged following removal of S-14 LI from pancreatic extracts by affinity chromatography before gel filtration. Serial dilutions of fractions containing 9-11,000 and 1,200 mol wt materials exhibited parallelism with synthetic S-28(1-12). The total pancreatic concentration of S-28(1-12) LI was 1.56 pmol/mg protein, of which S-28(1-12) accounted for 0.83 pmol/mg protein and 9-11,000 S-28(1-12) LI comprised 0.55 pmol/mg protein. Pancreatic S-14 LI concentration was 2.07 pmol/mg protein, of which 98% corresponded to S-14. S-28-related peaks accounted for <1% of immunoreactivity in both RIAs. I concluded that (a) S-14 is the main form of pancreatic S-14 LI; (b) S-28 is present in very small quantities, in the pancreas; (c) S-28(1-12) LI consist mainly of S-28(1-12) and 9-11,000 mol wt S-28(1-12) LI; (d) 9-11,000 l wt S-28(1-12) LI could represent prosomatostatin without the S-14 sequence; (e) the finding of high concentrations of 9-11,000 mol wt S-28(1-12) LI suggests that S-14 synthesis can occur independently of S-28 and that direct processing of prosomatostatin is an important pathway for S-14 synthesis in the pancreas.

Full text

PDF
2138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benoit R., Böhlen P., Ling N., Briskin A., Esch F., Brazeau P., Ying S. Y., Guillemin R. Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci U S A. 1982 Feb;79(3):917–921. doi: 10.1073/pnas.79.3.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benoit R., Ling N., Bakhit C., Morrison J. H., Alford B., Guillemin R. Somatostatin-28(1-12)-like immunoreactivity in the rat. Endocrinology. 1982 Dec;111(6):2149–2151. doi: 10.1210/endo-111-6-2149. [DOI] [PubMed] [Google Scholar]
  3. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973 Jan 5;179(4068):77–79. doi: 10.1126/science.179.4068.77. [DOI] [PubMed] [Google Scholar]
  4. Esch F., Böhlen P., Ling N., Benoit R., Brazeau P., Guillemin R. Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6827–6831. doi: 10.1073/pnas.77.11.6827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fletcher D. J., Noe B. D., Bauer G. E., Quigley J. P. Characterization of the conversion of a somatostatin precursor to somatostatin by islet secretory granules. Diabetes. 1980 Aug;29(8):593–599. doi: 10.2337/diab.29.8.593. [DOI] [PubMed] [Google Scholar]
  6. Funckes C. L., Minth C. D., Deschenes R., Magazin M., Tavianini M. A., Sheets M., Collier K., Weith H. L., Aron D. C., Roos B. A. Cloning and characterization of a mRNA-encoding rat preprosomatostatin. J Biol Chem. 1983 Jul 25;258(14):8781–8787. [PubMed] [Google Scholar]
  7. Goodman R. H., Aron D. C., Roos B. A. Rat pre-prosomatostatin. Structure and processing by microsomal membranes. J Biol Chem. 1983 May 10;258(9):5570–5573. [PubMed] [Google Scholar]
  8. Goodman R. H., Lund P. K., Jacobs J. W., Habener J. F. Pre-prosomatostatins. Products of cell-free translations of messenger RNAs from anglerfish islets. J Biol Chem. 1980 Jul 25;255(14):6549–6552. [PubMed] [Google Scholar]
  9. Hobart P., Crawford R., Shen L., Pictet R., Rutter W. J. Cloning and sequence analysis of cDNAs encoding two distinct somatostatin precursors found in the endocrine pancreas of anglerfish. Nature. 1980 Nov 13;288(5787):137–141. doi: 10.1038/288137a0. [DOI] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Noe B. D., Fletcher D. J., Bauer G. E., Weir G. C., Patel Y. Somatostatin biosynthesis occurs in pancreatic islets. Endocrinology. 1978 Jun;102(6):1675–1685. doi: 10.1210/endo-102-6-1675. [DOI] [PubMed] [Google Scholar]
  12. Patel Y. C., Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology. 1978 Feb;102(2):523–530. doi: 10.1210/endo-102-2-523. [DOI] [PubMed] [Google Scholar]
  13. Patel Y. C., Wheatley T., Ning C. Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and nonneural tissues and portal plasma of the rat. Endocrinology. 1981 Dec;109(6):1943–1949. doi: 10.1210/endo-109-6-1943. [DOI] [PubMed] [Google Scholar]
  14. Patzelt C., Tager H. S., Carroll R. J., Steiner D. F. Identification of prosomatostatin in pancreatic islets. Proc Natl Acad Sci U S A. 1980 May;77(5):2410–2414. doi: 10.1073/pnas.77.5.2410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pradayrol L., Jörnvall H., Mutt V., Ribet A. N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett. 1980 Jan 1;109(1):55–58. doi: 10.1016/0014-5793(80)81310-x. [DOI] [PubMed] [Google Scholar]
  16. Schally A. V., Huang W. Y., Chang R. C., Arimura A., Redding T. W., Millar R. P., Hunkapiller M. W., Hood L. E. Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4489–4493. doi: 10.1073/pnas.77.8.4489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shen L. P., Pictet R. L., Rutter W. J. Human somatostatin I: sequence of the cDNA. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4575–4579. doi: 10.1073/pnas.79.15.4575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shields D. In vitro biosynthesis of somatostatin. Evidence for two distinct preprosomatostatin molecules. J Biol Chem. 1980 Dec 25;255(24):11625–11628. [PubMed] [Google Scholar]
  19. Spiess J., Vale W. Multiple forms of somatostatin-like activity in rat hypothalamus. Biochemistry. 1980 Jun 24;19(13):2861–2866. doi: 10.1021/bi00554a007. [DOI] [PubMed] [Google Scholar]
  20. Trent D. F., Weir G. C. Heterogeneity of somatostatin-like peptides in rat brain, pancreas, and gastrointestinal tract. Endocrinology. 1981 Jun;108(6):2033–2038. doi: 10.1210/endo-108-6-2033. [DOI] [PubMed] [Google Scholar]
  21. Zingg H. H., Patel Y. C. Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture. J Clin Invest. 1982 Nov;70(5):1101–1109. doi: 10.1172/JCI110698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zingg H. H., Patel Y. C. Processing of somatostatin precursors: evidence for enzymatic cleavage by hypothalamic extract. Biochem Biophys Res Commun. 1980 Apr 29;93(4):1274–1279. doi: 10.1016/0006-291x(80)90627-0. [DOI] [PubMed] [Google Scholar]
  23. Zingg H. H., Patel Y. C. Processing of synthetic somatostatin-28 and a related endogenous rat hypothalamic somatostatin-like molecule by hypothalamic enzymes. Life Sci. 1982 Feb 7;30(6):525–533. doi: 10.1016/0024-3205(82)90265-x. [DOI] [PubMed] [Google Scholar]
  24. Zyznar E. S., Conlon J. M., Schusdziarra V., Unger R. H. Properties of somatostatin-like immunoreactive polypeptides in the canine extrahypothalamic brain and stomach. Endocrinology. 1979 Dec;105(6):1426–1431. doi: 10.1210/endo-105-6-1426. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES